Intellia slips after mid-stage data for CRISPR-based hereditary angioedema therapy
Intellia Therapeutics (NASDAQ:NTLA) fell ~9% in the pre-market on Thursday after the biotech announced data from an ongoing ...
Wall Street's S&P 500 index is broadening out in the second half of 2024
BMO Capital Markets notes a shift in S&P 500 dynamics as more stocks outperform, signaling potential opportunities for stock ...
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
New drug approvals and strong pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position EXEL, ...
U.S. Composite PMI inches up in October, driven by service sector
S&P Global U.S. Composite PMI (preliminary) edged up to 54.3 in October from 54.0 in September, signaling a slightly faster ...
MIT Technology Review2m
Now read the rest of The Algorithm
Is technology helping—or harming—our food supply? Novelist Sean Michaels envisions what life will look like 125 years from ...